Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition

Author:

Bertels Zachariah1,Singh Harinder2ORCID,Dripps Isaac1,Siegersma Kendra1,Tipton Alycia F1,Witkowski Wiktor D1,Sheets Zoie1,Shah Pal1,Conway Catherine1,Mangutov Elizaveta1,Ao Mei2,Petukhova Valentina3,Karumudi Bhargava3,Petukhov Pavel A3,Baca Serapio M45,Rasenick Mark M126,Pradhan Amynah A1ORCID

Affiliation:

1. Department of Psychiatry, University of Illinois at Chicago, Chicago, United States

2. Department of Physiology and Biophysics, University of Illinois at Chicago, Chicago, United States

3. Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago, Chicago, United States

4. Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, United States

5. Department of Neurology, University of Colorado Anschutz Medical Campus, Aurora, United States

6. Jesse Brown VAMC, Chicago, United States

Abstract

Migraine is the sixth most prevalent disease worldwide but the mechanisms that underlie migraine chronicity are poorly understood. Cytoskeletal flexibility is fundamental to neuronal-plasticity and is dependent on dynamic microtubules. Histone-deacetylase-6 (HDAC6) decreases microtubule dynamics by deacetylating its primary substrate, α-tubulin. We use validated mouse models of migraine to show that HDAC6-inhibition is a promising migraine treatment and reveal an undiscovered cytoarchitectural basis for migraine chronicity. The human migraine trigger, nitroglycerin, produced chronic migraine-associated pain and decreased neurite growth in headache-processing regions, which were reversed by HDAC6 inhibition. Cortical spreading depression (CSD), a physiological correlate of migraine aura, also decreased cortical neurite growth, while HDAC6-inhibitor restored neuronal complexity and decreased CSD. Importantly, a calcitonin gene-related peptide receptor antagonist also restored blunted neuronal complexity induced by nitroglycerin. Our results demonstrate that disruptions in neuronal cytoarchitecture are a feature of chronic migraine, and effective migraine therapies might include agents that restore microtubule/neuronal plasticity.

Funder

National Institute of Neurological Disorders and Stroke

National Institute on Drug Abuse

National Center for Complementary and Integrative Health

Center for Integrated Healthcare, U.S. Department of Veterans Affairs

Amgen Foundation

Center for Clinical and Translational Science, University of Illinois at Chicago

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3